Cargando…

Statins Do Not Influence Long-Term Rituximab Clinical Efficiency in Rheumatoid Arthritis Patients

Objective. This longitudinal study aims to determine if statins inhibit the response to rituximab in rheumatoid arthritis (RA) patients. Methods. 41 patients initiating rituximab were included; 17 patients were exposed to the combination of statins and rituximab. The total cholesterol, erythrocyte s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazilu, Diana, Gudu, Tania, Ionescu, Ruxandra, Opris, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912821/ https://www.ncbi.nlm.nih.gov/pubmed/24511542 http://dx.doi.org/10.1155/2014/689426

Ejemplares similares

Monitoring Drug and Antidrug Levels: A Rational Approach in Rheumatoid Arthritis Patients Treated with Biologic Agents Who Experience Inadequate Response While Being on a Stable Biologic Treatment
por: Mazilu, Diana, et al.
Publicado: (2014)

Whole Body Bone Tissue and Cardiovascular Risk in Rheumatoid Arthritis
por: Popescu, Claudiu, et al.
Publicado: (2014)

Therapeutic approach to patients with rheumatoid arthritis and chronic HBV/HCV infection
por: Daia-Iliescu, Sînziana, et al.
Publicado: (2014)

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis
por: Lehane, P B, et al.
Publicado: (2014)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Long-term persistence with rituximab in patients with rheumatoid arthritis
por: Oldroyd, Alexander G S, et al.
Publicado: (2018)

Original papers: clinical or basic research anti-cyclic citrullinated peptide antibodies - activity markers in rheumatoid arthritis
por: Predeteanu, Denisa, et al.
Publicado: (2009)

Rituximab for the treatment of rheumatoid arthritis: an update
por: Mok, Chi Chiu
Publicado: (2013)

Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial
por: den Broeder, Alfons A., et al.
Publicado: (2017)

Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis
por: Barakat, Athar, et al.
Publicado: (2014)

Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis
por: Duroux-Richard, Isabelle, et al.
Publicado: (2014)

Rituximab and its potential for the treatment of rheumatoid arthritis
por: Bryant, Adam, et al.
Publicado: (2006)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Tsiakalos, Aristotelis P, et al.
Publicado: (2008)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Update on the use of rituximab for intractable rheumatoid arthritis
por: Looney, R John
Publicado: (2009)

Interferon in systemic lupus erythematosus—A halfway between monogenic autoinflammatory and autoimmune disease
por: Saulescu, Ioana, et al.
Publicado: (2022)

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Reddy, Venkat, et al.
Publicado: (2015)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Rituximab treatment in rheumatoid arthritis: how does it work?
por: Boumans, Maria JH, et al.
Publicado: (2009)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
por: Kilic, Levent, et al.
Publicado: (2018)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy, Hasan, et al.
Publicado: (2020)

Systemic manifestations of chronic hepatitis C - results from a study performed in a rheumatology clinic
por: Daia, Elena-Sînziana, et al.
Publicado: (2013)

Outcome of rheumatoid arthritis following adjunct statin therapy
por: Das, Subham, et al.
Publicado: (2015)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Tuscano, Joseph M, et al.
Publicado: (2009)

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011)

Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis
por: Sweeney, Shannon R, et al.
Publicado: (2016)

(Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges
por: den Broeder, Alfons A, et al.
Publicado: (2021)

Enteroviral Meningoencephalitis as a Complication of Rituximab Therapy for Rheumatoid Arthritis
por: Cook, Samuel G, et al.
Publicado: (2021)

The Potential Effect of Statins on Rituximab Immunotherapy
por: Cragg, Mark S
Publicado: (2008)

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
por: Lurati, Alfredomaria, et al.
Publicado: (2012)

Long‐Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five‐Year Observational Study
por: Winthrop, Kevin L., et al.
Publicado: (2019)

Long-term persistence of rituximab in patients with rheumatoid arthritis: an evaluation of the UCL cohort from 1998 to 2020
por: Norris-Grey, Caitlin, et al.
Publicado: (2021)

Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic
por: Łosińska, Katarzyna, et al.
Publicado: (2022)

Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study
por: Kastbom, Alf, et al.
Publicado: (2012)

The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis
por: Novikova, Diana S., et al.
Publicado: (2016)

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
por: Hainsworth, John D
Publicado: (2003)

Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
por: Mishra, Richa, et al.
Publicado: (2009)

Marked deterioration in rheumatoid arthritis associated bronchiectasis following treatment with Rituximab
por: Musameh, K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u8g3g0m90r6c7juk4ko1sk7kv5